New ways to treat bacterial infections (Q35053125)

6 August 2017

1 reference

title

New ways to treat bacterial infections (English)

1 reference

6 August 2017

Peter W Taylor

1

1 reference

PubMed ID

12546840

6 August 2017

Paul D Stapleton

series ordinal

2

1 reference

PubMed ID

12546840

6 August 2017

J Paul Luzio

series ordinal

3

1 reference

6 August 2017

1 November 2002

1 reference

6 August 2017

1 reference

6 August 2017

7

1 reference

6 August 2017

21

1 reference

6 August 2017

1086-1091

1 reference

Review article: Helicobacter pylori infection from pathogenesis to treatment--a critical reappraisal

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Risk factors for the spread of antibiotic-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Molecular strategies for overcoming antibiotic resistance in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on susceptibility of Escherichia coli to amoxicillin-clavul

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Structure-activity relationships of biphenyl tetrazoles as metallo-beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Antimicrobial properties of tea (Camellia sinensis L.).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Mechanisms of methicillin resistance in staphylococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Activity of the tea component epicatechin gallate and analogues against methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Methicillin resistance in Staphylococcus aureus: mechanisms and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Phenotypic conversion of drug-resistant bacteria to drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

THE ACTION OF A SPECIFIC ENZYME UPON THE DERMAL INFECTION OF RABBITS WITH TYPE III PNEUMOCOCCUS.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Photodynamic antimicrobial chemotherapy (PACT)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

1 reference

7 January 2021

Lethal photosensitisation of Staphylococcus aureus in vitro: effect of growth phase, serum, and pre-irradiation time

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Killing of Streptococcus sanguis in biofilms using a light-activated antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Structure-activity relationship of porphines for photoinactivation of bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Bacteriophages show promise as antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

Long-circulating bacteriophage as antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902498-4

7 January 2021

10.1016/S1359-6446(02)02498-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12546840